Free Trial

Siga Technologies (SIGA) Competitors

Siga Technologies logo
$6.80 +0.03 (+0.37%)
As of 10:21 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SIGA vs. IRON, BLTE, CNTA, HRMY, ADPT, SRPT, TARS, IMCR, ARQT, and SPRY

Should you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include Disc Medicine (IRON), Belite Bio (BLTE), Centessa Pharmaceuticals (CNTA), Harmony Biosciences (HRMY), Adaptive Biotechnologies (ADPT), Sarepta Therapeutics (SRPT), Tarsus Pharmaceuticals (TARS), Immunocore (IMCR), Arcutis Biotherapeutics (ARQT), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical products" industry.

Siga Technologies vs. Its Competitors

Disc Medicine (NASDAQ:IRON) and Siga Technologies (NASDAQ:SIGA) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

In the previous week, Disc Medicine had 4 more articles in the media than Siga Technologies. MarketBeat recorded 7 mentions for Disc Medicine and 3 mentions for Siga Technologies. Disc Medicine's average media sentiment score of 0.75 beat Siga Technologies' score of 0.67 indicating that Disc Medicine is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Disc Medicine
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Siga Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

83.7% of Disc Medicine shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 4.2% of Disc Medicine shares are owned by company insiders. Comparatively, 2.0% of Siga Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Disc Medicine has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Siga Technologies has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.

Siga Technologies has a net margin of 40.30% compared to Disc Medicine's net margin of 0.00%. Siga Technologies' return on equity of 25.21% beat Disc Medicine's return on equity.

Company Net Margins Return on Equity Return on Assets
Disc MedicineN/A -22.61% -21.07%
Siga Technologies 40.30%25.21%22.05%

Siga Technologies has higher revenue and earnings than Disc Medicine. Disc Medicine is trading at a lower price-to-earnings ratio than Siga Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Disc MedicineN/AN/A-$109.36M-$3.92-14.84
Siga Technologies$120.33M4.04$59.21M$0.6710.16

Disc Medicine presently has a consensus target price of $96.70, suggesting a potential upside of 66.27%. Given Disc Medicine's stronger consensus rating and higher probable upside, research analysts plainly believe Disc Medicine is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Disc Medicine
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.09
Siga Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Disc Medicine and Siga Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

MetricSiga TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$486.87M$2.45B$5.52B$9.35B
Dividend YieldN/A1.79%4.25%4.09%
P/E Ratio10.179.2227.9519.83
Price / Sales4.04761.91438.79106.18
Price / Cash8.01160.6835.5357.53
Price / Book2.254.718.255.72
Net Income$59.21M$30.99M$3.23B$257.51M
7 Day Performance-1.38%0.47%-0.13%0.59%
1 Month Performance8.02%9.59%7.21%10.74%
1 Year Performance-24.47%-3.76%27.45%15.87%

Siga Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
Siga Technologies
1.9841 of 5 stars
$6.81
+0.4%
N/A-26.9%$486.87M$120.33M10.1740
IRON
Disc Medicine
3.2355 of 5 stars
$53.38
-2.5%
$96.70
+81.2%
+19.7%$1.90BN/A-13.6230Insider Trade
BLTE
Belite Bio
1.9919 of 5 stars
$58.63
-1.4%
$96.67
+64.9%
+27.8%$1.89BN/A-43.1110
CNTA
Centessa Pharmaceuticals
3.1949 of 5 stars
$13.62
-3.2%
$27.89
+104.8%
+57.6%$1.88B$6.85M-7.52200
HRMY
Harmony Biosciences
4.8399 of 5 stars
$32.24
+0.2%
$53.63
+66.3%
+1.4%$1.85B$714.73M12.31200Positive News
ADPT
Adaptive Biotechnologies
2.6988 of 5 stars
$11.74
-0.5%
$10.57
-10.0%
+143.4%$1.79B$178.96M-12.23790
SRPT
Sarepta Therapeutics
4.7364 of 5 stars
$17.32
-5.0%
$60.88
+251.5%
-87.7%$1.79B$1.90B-6.441,372Trending News
Analyst Forecast
Gap Up
TARS
Tarsus Pharmaceuticals
1.7819 of 5 stars
$39.93
-3.0%
$66.67
+67.0%
+45.9%$1.73B$182.95M-14.6350News Coverage
Positive News
Analyst Revision
IMCR
Immunocore
1.318 of 5 stars
$32.41
-1.8%
$58.89
+81.7%
-13.9%$1.66B$310.20M-75.37320
ARQT
Arcutis Biotherapeutics
1.2713 of 5 stars
$13.39
-3.1%
$18.80
+40.4%
+44.6%$1.65B$196.54M-12.88150Insider Trade
SPRY
ARS Pharmaceuticals
2.8408 of 5 stars
$17.09
+3.5%
$31.00
+81.4%
+57.6%$1.62B$89.15M-106.8190

Related Companies and Tools


This page (NASDAQ:SIGA) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners